145 related articles for article (PubMed ID: 11908742)
1. Diffuse large B-cell lymphoma: a clinicopathologic analysis of 444 cases classified according to the updated Kiel classification.
Diebold J; Anderson JR; Armitage JO; Connors JM; Maclennan KA; Müller-Hermelink HK; Nathwani BN; Ullrich F; Weisenburger DD
Leuk Lymphoma; 2002 Jan; 43(1):97-104. PubMed ID: 11908742
[TBL] [Abstract][Full Text] [Related]
2. Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.
Engelhard M; Brittinger G; Huhn D; Gerhartz HH; Meusers P; Siegert W; Thiel E; Wilmanns W; Aydemir U; Bierwolf S; Griesser H; Tiemann M; Lennert K
Blood; 1997 Apr; 89(7):2291-7. PubMed ID: 9116271
[TBL] [Abstract][Full Text] [Related]
3. Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome.
Simonitsch-Klupp I; Hauser I; Ott G; Drach J; Ackermann J; Kaufmann J; Weltermann A; Greinix HT; Skrabs C; Dittrich C; Lutz D; Pötter R; Mannhalter C; Lechner K; Chott A; Jaeger U
Leukemia; 2004 Jan; 18(1):146-55. PubMed ID: 14603341
[TBL] [Abstract][Full Text] [Related]
4. Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis.
de Bruin PC; Noorduyn AL; van der Valk P; van Heerde P; van Diest PJ; van de Sandt MM; Ossenkoppele GJ; Meijer CJ
Cancer; 1993 Apr; 71(8):2604-12. PubMed ID: 8453584
[TBL] [Abstract][Full Text] [Related]
5. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
[TBL] [Abstract][Full Text] [Related]
6. Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification.
Baars JW; de Jong D; Willemse EM; Gras L; Dalesio O; v Heerde P; Huygens PC; vd Lelie H; Kr vd Borne AE
Br J Cancer; 1999 Apr; 79(11-12):1770-6. PubMed ID: 10206291
[TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma: is morphologic subdivision useful in clinical management?
Salar A; Fernández de Sevilla A; Romagosa V; Domingo-Claros A; González-Barca E; Pera J; Climent J; Grañena A
Eur J Haematol; 1998 Mar; 60(3):202-8. PubMed ID: 9580245
[TBL] [Abstract][Full Text] [Related]
8. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project.
Weisenburger DD; Anderson JR; Diebold J; Gascoyne RD; MacLennan KA; Müller-Hermelink HK; Nathwani BN; Ullrich F; Armitage JO
Am J Hematol; 2001 Jul; 67(3):172-8. PubMed ID: 11391714
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma.
Melnyk A; Rodriguez A; Pugh WC; Cabannillas F
Blood; 1997 Jun; 89(12):4514-20. PubMed ID: 9192775
[TBL] [Abstract][Full Text] [Related]
10. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.
Arrowsmith ER; Macon WR; Kinney MC; Stein RS; Goodman SA; Morgan DS; Flexner JM; Cousar JB; Jagasia MH; McCurley TL; Greer JP
Leuk Lymphoma; 2003 Feb; 44(2):241-9. PubMed ID: 12688340
[TBL] [Abstract][Full Text] [Related]
11. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.
Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL
Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study Group.
Schlegelberger B; Zwingers T; Harder L; Nowotny H; Siebert R; Vesely M; Bartels H; Sonnen R; Hopfinger G; Nader A; Ott G; Müller-Hermelink K; Feller A; Heinz R
Blood; 1999 Nov; 94(9):3114-20. PubMed ID: 10556197
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow-up study on 54 cases. French Study Group for Cutaneous Lymphomas.
Joly P; Vasseur E; Esteve E; Leibowitch M; Tilly H; Vaillant L; Wechsler J; Thomine E; De Muret A; Dreyfus F
Br J Dermatol; 1995 Apr; 132(4):506-12. PubMed ID: 7748738
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
15. Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.
De Paepe P; Achten R; Verhoef G; Wlodarska I; Stul M; Vanhentenrijk V; Praet M; De Wolf-Peeters C
J Clin Oncol; 2005 Oct; 23(28):7060-8. PubMed ID: 16129841
[TBL] [Abstract][Full Text] [Related]
16. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
17. Incidence, presenting features and prognosis of low-grade B-cell non-Hodgkin's lymphomas. Population-based data from a Danish lymphoma registry.
D'Amore F; Christensen BE; Thorling K; Pedersen M; Jensen MK; Boesen AM; Andersen E; Johansen P; Mortensen LS
Leuk Lymphoma; 1993 Dec; 12(1-2):69-77. PubMed ID: 8161937
[TBL] [Abstract][Full Text] [Related]
18. [Diffuse large B-cell lymphoma with expression of anaplastic lymphoma kinase protein: clinicopathologic and immunohistochemical study of 5 cases].
Wang WY; Ma ZG; Li GD; Liu WP; Zhong L; Wang Y; Li JM; Li L; Jiang W; Tang Y; Liao DY
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):529-34. PubMed ID: 17134546
[TBL] [Abstract][Full Text] [Related]
19. Immunoblastic morphology in diffuse large B-cell lymphoma is associated with a nongerminal center immunophenotypic profile.
Camara DA; Stefanoff CG; Pires AR; Soares F; Biasoli I; Zalcberg I; Spector N; Lopes VS; Morais JC
Leuk Lymphoma; 2007 May; 48(5):892-6. PubMed ID: 17487732
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
